After 3 injections of MSCs separated by intervals of 7 days, the tumor sizes of the mice that received IFNα-AF-MSCs started to show significant difference compared with those of the control group (P < 0.05) since day 20. The gene discussed is IFNA1; the disease is neoplasm.